About Index Trending news
Lists
Pricing
Lion Biotechnologies

Lion Biotechnologies

Lion Biotechnologies

We are a publicly traded #biotech company focused on the development of novel #cancer #immunotherapy products for #melanoma and other solid tumors.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$100,000,000
Employees

Unknown size

Locations
HQ
Headquarters
The Motley Fool

Why Lion Biotechnologies Inc. Stock Is Roaring Higher Today

$100,000,000 Post-IPO equity
PE Hub

Lion Biotechnologies racks up $100 mln, also hires new president/CEO